EGFR and sarcoma: Gliosarcoma, however, does not exhibit amplification or mutations of EGFR at the same frequency, suggesting there may be additional/alternate mechanisms propelling tumorigenesis and potentially mesenchymal transition into a sarcoma phenotype.